Efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis (RRMS) in the 120-week extension to the CLARITY study

被引：0

作者：

Giovannoni, Gavin ^{[1
]}

Comi, Giancarlo ^{[2
,3
]}

Cook, Stuart ^{[4
]}

Rieckmann, Peter ^{[5
,6
]}

Rammohan, Kottil ^{[7
]}

Soelberg-Soerensen, Per ^{[8
]}

Vermersch, Patrick ^{[9
]}

Martin, Emily ^{[10
]}

Dangond, Fernando ^{[10
]}

机构：

[1] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England

[2] Univ Vita Salute San Raffaele, Osped San Raffaele, Dept Neurol, Milan, Italy

[3] Univ Vita Salute San Raffaele, Osped San Raffaele, Inst Expt Neurol, Milan, Italy

[4] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA

[5] Med Pk Loipl, Hosp Nervous Dis, Erlangen, Germany

[6] Univ Erlangen Nurnberg, Erlangen, Germany

[7] Univ Miami, Miller Sch Med, Dept Neurol, MS Res Ctr, Miami, FL 33136 USA

[8] Copenhagen Univ Hosp, Dept Neurol, Danish Multiple Sclerosis Ctr, Copenhagen, Denmark

[9] Univ Lille Nord France, Pole Neurol, Hop R Salengro, Lille, France

[10] EMD Serono Inc, Billerica, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：NP6 / NP7

页数：2